Alumni Ventures

Tracked participation in 5 Atlas companies, with 0 explicitly attributed leads.

Firm website ↗

5portfolio companies

6round participations

0lead positions

Nov 2025latest activity

Capital activity

Portfolio

CompanyLatest valuationFirst → latestRoundsRoleAttributed partner

ITIambic TherapeuticsScienceIambic Therapeutics (formerly Entos) is a clinical-stage life science and technology company developing…$8.4Mvaluation$476MraisedRecent roundsOversubscribed financing round (company described as >$100M) · Nov 2025$100M · Abingworth, Alexandria Venture Investments +15Series B extension (oversubscribed) · Jun 2024$50M · led by Exor Ventures, Mubadala CapitalSeries B (oversubscribed) · Oct 2023$100M · led by Abingworth, Ascenta CapitalIambic Therapeutics—Nov 2025 → Nov 20251 roundParticipant—

LSLila SciencesScienceLila Sciences (website: lila.ai) builds what it calls an “operating system for science,” combining an AI reasoning…$1.3Bvaluation$1.1BraisedRecent roundsSeries A extension (NVIDIA-backed) · Oct 2025$115M · Abu Dhabi Investment Authority (ADIA) (subsidiary), Flagship Pioneering +2Series A · Oct 2025$350M · led by Braidwell, Collective GlobalSeed · Oct 2025$200M · Abu Dhabi Investment Authority (ADIA) subsidiary, Altitude Life Science Ventures +7Lila Sciences—Sep 2025 → Oct 20252 roundsParticipant—

EAEnCharge AI—Dec 2022 → Dec 20221 roundParticipant—

BBeam—May 2022 → May 20221 roundParticipant—

DADuality AI—— → —1 roundParticipant—

DateCompanyRoundRaisedValuationRoleEvidence

Nov 10, 2025ITIambic TherapeuticsScienceIambic Therapeutics (formerly Entos) is a clinical-stage life science and technology company developing…$8.4Mvaluation$476MraisedRecent roundsOversubscribed financing round (company described as >$100M) · Nov 2025$100M · Abingworth, Alexandria Venture Investments +15Series B extension (oversubscribed) · Jun 2024$50M · led by Exor Ventures, Mubadala CapitalSeries B (oversubscribed) · Oct 2023$100M · led by Abingworth, Ascenta CapitalIambic TherapeuticsOversubscribed financing round (company described as >$100M)$100M—Participant

Source ↗

Oct 10, 2025LSLila SciencesScienceLila Sciences (website: lila.ai) builds what it calls an “operating system for science,” combining an AI reasoning…$1.3Bvaluation$1.1BraisedRecent roundsSeries A extension (NVIDIA-backed) · Oct 2025$115M · Abu Dhabi Investment Authority (ADIA) (subsidiary), Flagship Pioneering +2Series A · Oct 2025$350M · led by Braidwell, Collective GlobalSeed · Oct 2025$200M · Abu Dhabi Investment Authority (ADIA) subsidiary, Altitude Life Science Ventures +7Lila SciencesSeries A$350M—Participant

Source ↗

Sep 15, 2025LSLila SciencesScienceLila Sciences (website: lila.ai) builds what it calls an “operating system for science,” combining an AI reasoning…$1.3Bvaluation$1.1BraisedRecent roundsSeries A extension (NVIDIA-backed) · Oct 2025$115M · Abu Dhabi Investment Authority (ADIA) (subsidiary), Flagship Pioneering +2Series A · Oct 2025$350M · led by Braidwell, Collective GlobalSeed · Oct 2025$200M · Abu Dhabi Investment Authority (ADIA) subsidiary, Altitude Life Science Ventures +7Lila SciencesSeries A$235M—Participant

Source ↗

Dec 14, 2022EAEnCharge AISeries A$21.7M—Participant

Source ↗

May 10, 2022BBeamSeed$3.5M—Participant

Source ↗

UndatedDADuality AISeed$3.1M—Participant

Source ↗

DateCompanyRoundRaisedValuationRoleEvidence

Source ↗

Dec 14, 2022EAEnCharge AISeries A$21.7M—Participant

Source ↗

May 10, 2022BBeamSeed$3.5M—Participant

Source ↗

UndatedDADuality AISeed$3.1M—Participant

Source ↗